Skip to content

Exercise, PNE and Cognitive Training in Individuals With Chronic Low Back Pain

Pain Neuroscience Education, Exercise, and Cognitive Training in Individuals With Idiopathic Chronic Low Back Pain: a Three-arm Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05777343
Enrollment
83
Registered
2023-03-21
Start date
2023-04-10
Completion date
2024-03-01
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low-back Pain

Keywords

cognitive training, exercise, chronic low back pain, pain neuroscience education

Brief summary

This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).

Detailed description

This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education (PNE) will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP). It will have three arms of which will receive exercise, PNE and/or cognitive training for 8 weeks (Group I - exercise and PNE; Group II - exercise, PNE and cognitive training; Group III - cognitive training). Participants will be assessed for pain characteristics, psychological, and cognitive aspects at baseline, post-intervention and at 3 months follow-up.

Interventions

OTHERExperimental

Cognitive training combined with the recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).

OTHERExercise and PNE

Recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).

OTHERCognitive training

Online sessions of cognitive training.

Sponsors

Fundação para a Ciência e a Tecnologia
CollaboratorOTHER
RISE Study Group
CollaboratorNETWORK
Aveiro University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* have chronic idiopathic LBP * report pain intensity of at least 2 out of 10 on the Numeric Pain Rating Scale * 18 to 64 years old * Be able to read, write and speak Portuguese * Asses to personal computer and internet for those receiving cognitive training

Exclusion criteria

* individuals receiving any chronic treatment for their pain * symptoms of peripheral nervous system pathology (e.g., motor weakness and sensory disturbance); * a diagnosis of an ongoing neurological disease with peripheral or central nervous system involvement or relevant sequela; * having a diagnosis of ongoing psychiatric disease * having relevant cognitive impairment as assessed by Montreal Cognitive Assessment (MoCA).

Design outcomes

Primary

MeasureTime frameDescription
Numeric Pain Rating Scale Numeric Pain Rating ScalebaselineMeasured with a 11-point scale ranging from 0 meaning no pain to 10 meaning the worst pain imaginable.

Secondary

MeasureTime frameDescription
Roland Morris disability questionnairebaselineThe Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from 0 meaning no disability to 24 meaning maximum disability.
Central sensitization InventorybaselineThe central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points.
Hospital Anxiety and Depression Scale (HADS)baselineHADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between most of the times and not at all with higher scores indicating higher levels of anxiety and depression.
TAMPA Scale of KinesiophobiabaselineThe Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between strongly disagree and strongly agree. The total scores range from 0 to 52 points with higher levels indicating higher fear of movement.
Cognitive FunctionbaselineCognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance.
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)baselineThe scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep.
Two-point discriminationbaselineTwo-point discrimination is used to assess cortical reorganization.
Patient's Global Impression of Change (PGIC)post-intervention - 8 weeksPGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 (No change or condition worsened) to 7 (Much better, and with a considerable improvement that made all the difference) the statement that best reflected the impact of the intervention on their condition.
Pain Catastrophizing ScaleBaselineThe Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning not at all and 4 meaning all the time. The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing.

Countries

Portugal

Contacts

Primary ContactEllen P. Nery, Ms.
ellen.nery@ua.pt+351234370200
Backup ContactAnabela Silva
asilva@ua.pt+351234370200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026